A novel patient-centered "intention-to-treat" metric of U.S. lung transplant center performance

Am J Transplant. 2018 Jan;18(1):226-231. doi: 10.1111/ajt.14486. Epub 2017 Sep 26.

Abstract

Despite the importance of pretransplantation outcomes, 1-year posttransplantation survival is typically considered the primary metric of lung transplant center performance in the United States. We designed a novel lung transplant center performance metric that incorporates both pre- and posttransplantation survival time. We performed an ecologic study of 12 187 lung transplant candidates listed at 56 U.S. lung transplant centers between 2006 and 2012. We calculated an "intention-to-treat" survival (ITTS) metric as the percentage of waiting list candidates surviving at least 1 year after transplantation. The median center-level 1-year posttransplantation survival rate was 84.1%, and the median center-level ITTS was 66.9% (mean absolute difference 19.6%, 95% limits of agreement 4.3 to 35.1%). All but 10 centers had ITTS values that were significantly lower than 1-year posttransplantation survival rates. Observed ITTS was significantly lower than expected ITTS for 7 centers. These data show that one third of lung transplant candidates do not survive 1 year after transplantation, and that 12% of centers have lower than expected ITTS. An "intention-to-treat" survival metric may provide a more realistic expectation of patient outcomes at transplant centers and may be of value to transplant centers and policymakers.

Keywords: health services and outcomes research; lung transplantation/pulmonology; patient survival; registry/registry analysis; waitlist management.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Hospitals / standards*
  • Humans
  • Intention to Treat Analysis*
  • Lung Transplantation / mortality*
  • Male
  • Middle Aged
  • Patient Selection*
  • Patient-Centered Care*
  • Practice Patterns, Physicians' / standards*
  • Prognosis
  • Survival Rate
  • Tissue and Organ Procurement
  • Waiting Lists*